Transfusion Replacement Strategies in Jehovah's Witnesses and Others Who Decline Blood Products

被引:0
|
作者
DeLoughery, Thomas G. [1 ,2 ,3 ]
机构
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Med, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Pathol, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Pediat, Portland, OR 97239 USA
关键词
Blood transfusion; erythropoiesis-stimulating agents; Jehovah's Witnesses; tranexamic acid; RECOMBINANT FACTOR VIIA; POSTPARTUM HEMORRHAGE; TRANEXAMIC ACID; IRON-DEFICIENCY; TRAUMA PATIENTS; MANAGEMENT; CANCER; MORTALITY; ANEMIA; COAGULOPATHY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of blood transfusions is a mainstay of modern medical practice. Jehovah's Witnesses decline the use of blood transfusions as a matter of faith, however, and other patients do so for personal reasons. In all cases, it is important to document what blood products can or cannot be used. It is also essential to test all patients for iron deficiency, and to address any correctable factors in those who are anemic. This article reviews a variety of options that are available to aid in caring for patients who refuse blood transfusions, ranging from tranexamic acid to erythropoiesis-stimulating agents. With the use of these treatments, patients who decline blood transfusion can be safely managed in situations ranging from elective surgery to stem cell transplant to pregnancy.
引用
收藏
页码:826 / 836
页数:7
相关论文
共 50 条